Subjects | Field strength | N | Age (years) | Male/ female | LV EDV (ml) | LV mass (g) | LV EF (%) | |
---|---|---|---|---|---|---|---|---|
Evaluation | Healthy | 1.5 T & 3 T | 15 | 24 ± 4 | 7 / 8 | 187 ± 23.7 | 87 ± 20.9 | 62 ± 3.7 |
Validation | Healthy | 1.5 T | 14 | 53 ± 7 | 7 / 7 | 161 ± 18.3 | 81 ± 15.2 | 60 ± 3.6 |
Healthy | 3 T | 16 | 54 ± 3 | 11 / 5 | 170 ± 29.8 | 91 ± 24.1 | 62 ± 2.7 | |
Amyloidosis | 1.5 T | 25 | 66 ± 10 | 16 / 9 | 179 ± 35.4 | 178 ± 53 | 50 ± 11.2 | |
Amyloidosis | 3 T | 13 | 68 ± 12 | 13 / 0 | 165 ± 32.6 | 167 ± 40 | 52 ± 13.7 |